QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support

Redwood City, CA and Hilden, Germany – QIAGEN announced it has entered into an agreement to acquire N-of-One, Inc., a privately-held U.S. molecular decision support company and pioneer in clinical interpretation services for complex genomic data. The addition of N-of-One will enable QIAGEN to significantly expand its decision-support solutions while offering a broader range of software, content and service-based solutions. It will also enable QIAGEN to provide customers with greater access to valuable genomic data assets and service offerings.